|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 47/12 | |
| A61K 47/18 | |||
| A61K 38/00 |
| (11) | Patento numeris | 2699265 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12715107.4 |
| Europos patento paraiškos padavimo data | 2012-04-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-02-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-10-16 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2012/057119 |
| Data | 2012-04-19 |
| (87) | Numeris | WO 2012/143418 |
| Data | 2012-10-26 |
| (30) | Numeris | Data | Šalis |
| 11163171 | 2011-04-20 | EP |
| (72) |
DEUTEL, Britta, AT
LAUBER, Thomas, AT
FUERTINGER, Sabine, AT
|
| (73) |
Sandoz AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | STABLE PHARMACEUTICAL LIQUID FORMULATIONS OF THE FUSION PROTEIN TNFR:Fc |
| STABLE PHARMACEUTICAL LIQUID FORMULATIONS OF THE FUSION PROTEIN TNFR:Fc |